ES2162277T3 - Sustratos e inhibidores de enzimas proteoliticos. - Google Patents
Sustratos e inhibidores de enzimas proteoliticos.Info
- Publication number
- ES2162277T3 ES2162277T3 ES97918252T ES97918252T ES2162277T3 ES 2162277 T3 ES2162277 T3 ES 2162277T3 ES 97918252 T ES97918252 T ES 97918252T ES 97918252 T ES97918252 T ES 97918252T ES 2162277 T3 ES2162277 T3 ES 2162277T3
- Authority
- ES
- Spain
- Prior art keywords
- inhibitors
- substrates
- proteases
- proteolytic enzymes
- enzymes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003112 inhibitor Substances 0.000 title abstract 4
- 239000000758 substrate Substances 0.000 title abstract 3
- 102000004190 Enzymes Human genes 0.000 title 1
- 108090000790 Enzymes Proteins 0.000 title 1
- 230000002797 proteolythic effect Effects 0.000 title 1
- 102000035195 Peptidases Human genes 0.000 abstract 4
- 108091005804 Peptidases Proteins 0.000 abstract 4
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 102000004580 Aspartic Acid Proteases Human genes 0.000 abstract 1
- 108010017640 Aspartic Acid Proteases Proteins 0.000 abstract 1
- 102000005741 Metalloproteases Human genes 0.000 abstract 1
- 108010006035 Metalloproteases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 102000012479 Serine Proteases Human genes 0.000 abstract 1
- 108010022999 Serine Proteases Proteins 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00279—Features relating to reactor vessels
- B01J2219/00306—Reactor vessels in a multiple arrangement
- B01J2219/00313—Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
- B01J2219/00315—Microtiter plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00504—Pins
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B60/00—Apparatus specially adapted for use in combinatorial chemistry or with libraries
- C40B60/14—Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Enzymes And Modification Thereof (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9608457.9A GB9608457D0 (en) | 1996-04-24 | 1996-04-24 | Inhibitors of proteolytic enzymes |
| GBGB9616115.3A GB9616115D0 (en) | 1996-07-31 | 1996-07-31 | Substrate and inhibitors of proteolytic enzymes |
| GBGB9624584.0A GB9624584D0 (en) | 1996-11-27 | 1996-11-27 | Substances and inhibitors of proteolytic enzymes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2162277T3 true ES2162277T3 (es) | 2001-12-16 |
Family
ID=27268257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES97918252T Expired - Lifetime ES2162277T3 (es) | 1996-04-24 | 1997-04-24 | Sustratos e inhibidores de enzimas proteoliticos. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US6528275B1 (enExample) |
| EP (2) | EP0906334A1 (enExample) |
| JP (2) | JP2000512979A (enExample) |
| AT (1) | ATE203545T1 (enExample) |
| AU (2) | AU706855B2 (enExample) |
| CA (2) | CA2252508A1 (enExample) |
| DE (1) | DE69705838T2 (enExample) |
| DK (1) | DK0906333T3 (enExample) |
| ES (1) | ES2162277T3 (enExample) |
| WO (2) | WO1997040065A2 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6149869A (en) * | 1996-10-23 | 2000-11-21 | Glaxo Wellcome Inc. | Chemical synthesizers |
| US6042789A (en) * | 1996-10-23 | 2000-03-28 | Glaxo Group Limited | System for parallel synthesis of organic compounds |
| US6617114B1 (en) | 1996-10-31 | 2003-09-09 | Karo Bio Ab | Identification of drug complementary combinatorial libraries |
| JP2001510453A (ja) * | 1996-10-31 | 2001-07-31 | ノヴァロン ファーマスーチカル コーポレイション | 相補的組み合わせライブラリーを使用する薬剤の同定 |
| US6083761A (en) * | 1996-12-02 | 2000-07-04 | Glaxo Wellcome Inc. | Method and apparatus for transferring and combining reagents |
| US6054325A (en) * | 1996-12-02 | 2000-04-25 | Glaxo Wellcom Inc. | Method and apparatus for transferring and combining distinct chemical compositions with reagents |
| GB9722818D0 (en) * | 1997-10-30 | 1997-12-24 | Peptide Therapeutics Ltd | A method for mapping the active sites bound by enzymes that covalently modify substrate molecules |
| AU734992B2 (en) * | 1997-11-26 | 2001-06-28 | Medivir Uk Ltd | A solid-phase technology for the preparation of combinatorial libraries through amide-bond anchoring |
| US6083682A (en) | 1997-12-19 | 2000-07-04 | Glaxo Group Limited | System and method for solid-phase parallel synthesis of a combinatorial collection of compounds |
| MY153569A (en) | 1998-01-20 | 2015-02-27 | Mitsubishi Tanabe Pharma Corp | Inhibitors of ?4 mediated cell adhesion |
| US6569636B2 (en) | 1998-05-29 | 2003-05-27 | Hawaii Biotechnology Group, Inc. | Assay for modulators of metallo-enzyme activity |
| DE19925402C2 (de) * | 1999-06-02 | 2001-12-20 | Molecular Machines & Ind Gmbh | Screening von Target-Ligand-Wechselwirkungen |
| CA2398583A1 (en) | 2000-02-11 | 2001-08-16 | Cellomics, Inc. | Peptide biosensors for anthrax protease |
| JP2002250730A (ja) * | 2001-02-27 | 2002-09-06 | Shinwa Kako Kk | 分子センサー及びその製造方法 |
| MY140707A (en) | 2002-02-28 | 2010-01-15 | Mitsubishi Tanabe Pharma Corp | Process for preparing a phenylalanine derivative and intermediates thereof |
| WO2004014844A2 (en) * | 2002-08-09 | 2004-02-19 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds and methods to modulate coagulation |
| WO2005014534A1 (en) | 2003-08-08 | 2005-02-17 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions, and methods of use |
| US7208601B2 (en) * | 2003-08-08 | 2007-04-24 | Mjalli Adnan M M | Aryl and heteroaryl compounds, compositions, and methods of use |
| US8015064B2 (en) * | 2005-04-20 | 2011-09-06 | At&T Intellectual Property I, Lp | System and method of providing advertisements to cellular devices |
| DE602006009117D1 (de) * | 2005-07-26 | 2009-10-22 | Council Scient Ind Res | Verfahren zur identifizierung von die stresstoleranz in hefe erhöhenden genen sowie verwendung dieser gene zur verbesserung von hefestämmen |
| WO2010052244A1 (en) | 2008-11-05 | 2010-05-14 | Morphosys Ag | Deconvolution method |
| EP2189536A1 (en) * | 2008-11-20 | 2010-05-26 | Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO | Rapid FRET based anthrax diagnosis |
| JP5798487B2 (ja) * | 2008-11-20 | 2015-10-21 | ネーデルランドセ・オルガニサティ・フォール・トゥーヘパスト−ナトゥールウェテンスハッペライク・オンデルズーク・テーエヌオー | Ｆｒｅｔに基づく病原体の迅速診断 |
| EP3608317A1 (en) | 2012-01-12 | 2020-02-12 | Yale University | Compounds & methods for the enhanced degradation of targeted proteins & other polypeptides by an e3 ubiquitin ligase |
| GB201311888D0 (en) | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| GB201311891D0 (en) | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compound |
| US20180228907A1 (en) | 2014-04-14 | 2018-08-16 | Arvinas, Inc. | Cereblon ligands and bifunctional compounds comprising the same |
| BR112018008918A8 (pt) | 2015-11-02 | 2019-02-26 | Univ Yale | compostos de quimera proteólise dirigida e métodos para preparação e uso dos mesmos |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0428000A1 (en) | 1989-11-03 | 1991-05-22 | Abbott Laboratories | Fluorogenic substrates for the detection of proteolytic enzyme activity |
| US5164300A (en) | 1989-12-28 | 1992-11-17 | Washington University | Method for determining activity of retroviral protease |
| US5011910A (en) * | 1989-12-28 | 1991-04-30 | Washington University | Reagent and method for determining activity of retroviral protease |
| DK93990D0 (da) * | 1990-04-17 | 1990-04-17 | Carlsberg As | Fluorogene peptider og deres anvendelse ved bestemmelse af enzymatisk aktivitet |
| HU9201687D0 (en) | 1992-05-21 | 1992-08-28 | Arpad Furka | Preparation of sets from peptid mixtures with polycomponents and their use for the identification of biologically active peptides |
| US5585275A (en) * | 1992-09-02 | 1996-12-17 | Arris Pharmaceutical Corporation | Pilot apparatus for peptide synthesis and screening |
| SG48166A1 (en) | 1993-12-15 | 1998-04-17 | Conbichem Inc | Combinatorial libraries and methods for their use |
| US5506115A (en) | 1994-04-29 | 1996-04-09 | G. D. Searle & Co. | Reagent and method for determining activity of herpes protease |
| US5738996A (en) * | 1994-06-15 | 1998-04-14 | Pence, Inc. | Combinational library composition and method |
| EP1019528B1 (en) * | 1996-01-04 | 2003-10-29 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Method for assaying proteolytic enzymes using fluorescence-quenched substrates |
| US7135288B2 (en) * | 2002-09-27 | 2006-11-14 | Ut-Battelle, Llc | Combinatorial synthesis of ceramic materials |
-
1997
- 1997-04-24 EP EP97918253A patent/EP0906334A1/en not_active Withdrawn
- 1997-04-24 DE DE69705838T patent/DE69705838T2/de not_active Expired - Fee Related
- 1997-04-24 WO PCT/GB1997/001157 patent/WO1997040065A2/en not_active Ceased
- 1997-04-24 AT AT97918252T patent/ATE203545T1/de not_active IP Right Cessation
- 1997-04-24 ES ES97918252T patent/ES2162277T3/es not_active Expired - Lifetime
- 1997-04-24 AU AU26449/97A patent/AU706855B2/en not_active Ceased
- 1997-04-24 US US09/171,680 patent/US6528275B1/en not_active Expired - Fee Related
- 1997-04-24 CA CA002252508A patent/CA2252508A1/en not_active Abandoned
- 1997-04-24 JP JP09539622A patent/JP2000512979A/ja not_active Abandoned
- 1997-04-24 EP EP97918252A patent/EP0906333B1/en not_active Expired - Lifetime
- 1997-04-24 JP JP53786497A patent/JP4215822B2/ja not_active Expired - Fee Related
- 1997-04-24 WO PCT/GB1997/001158 patent/WO1997042216A1/en not_active Ceased
- 1997-04-24 CA CA002252408A patent/CA2252408A1/en not_active Abandoned
- 1997-04-24 DK DK97918252T patent/DK0906333T3/da active
- 1997-04-24 AU AU26450/97A patent/AU728263B2/en not_active Ceased
-
2002
- 2002-09-30 US US10/259,420 patent/US20030092067A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US6528275B1 (en) | 2003-03-04 |
| EP0906333A2 (en) | 1999-04-07 |
| AU728263B2 (en) | 2001-01-04 |
| EP0906334A1 (en) | 1999-04-07 |
| AU2645097A (en) | 1997-11-26 |
| CA2252408A1 (en) | 1997-11-13 |
| DE69705838T2 (de) | 2002-04-11 |
| US20030092067A1 (en) | 2003-05-15 |
| JP2000512979A (ja) | 2000-10-03 |
| DE69705838D1 (de) | 2001-08-30 |
| DK0906333T3 (da) | 2001-11-12 |
| AU2644997A (en) | 1997-11-12 |
| CA2252508A1 (en) | 1997-10-30 |
| EP0906333B1 (en) | 2001-07-25 |
| WO1997040065A3 (en) | 1997-12-04 |
| JP4215822B2 (ja) | 2009-01-28 |
| WO1997040065A2 (en) | 1997-10-30 |
| WO1997042216A1 (en) | 1997-11-13 |
| ATE203545T1 (de) | 2001-08-15 |
| JP2001501170A (ja) | 2001-01-30 |
| AU706855B2 (en) | 1999-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2162277T3 (es) | Sustratos e inhibidores de enzimas proteoliticos. | |
| ATE250066T1 (de) | Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen | |
| MY113489A (en) | Reversible protease inhibitors | |
| IL150168A0 (en) | Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods bsed thereon | |
| EA199700087A1 (ru) | Способ ингибирования катепсина к | |
| DE69938766D1 (de) | Verfahren zur Rückgewinnung von Substratscheiben | |
| NO20042609L (no) | Fremgangsmate for identifisering av tumormalrettede enzymer | |
| DE69828682D1 (de) | Nanomolare, non-peptidische inhibitoren von cathepsin d | |
| EA200001129A2 (ru) | Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина | |
| EP1032393A4 (en) | QUINOLIN-CONTAINING ALPHA-KETOAMIDE-BASED INHIBITORS OF CYSTEIN AND SERINE PROTEASE | |
| AU6458396A (en) | Phosphorous-containing cysteine and serine protease inhibitors | |
| ATE226254T1 (de) | Reagenz zur behandlung von arthritischen zustaenden | |
| DE60124289D1 (de) | Verfahren zur herstellung von 21-hydroxy-6,19-oxidoprogesteron (21oh-6op) | |
| WO2004042352A3 (en) | Substrates of n-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates | |
| MX9805948A (es) | Substratos e inhibidores para proteasa de cisteina ich-1. | |
| DE69835376D1 (de) | Verfahren zum auffinden von verbindungen zur vorbeugung von infektion oder pathogenizität | |
| DK1385993T3 (da) | Fremgangsmåde til detektering og behandling af tuberøs sclerose kompleksrelaterede lidelser | |
| AR027327A1 (es) | Procedimiento para la separacion einzimatica de racematos de derivados de aminometil-aril-ciclohezanol | |
| DE69630969T2 (de) | Verfahren zur hemmung des plasminogen-aktivator-inhibitors | |
| DE50105206D1 (de) | Verfahren zum selektieren von inhibitoren für enzyme | |
| WO2003092719A3 (en) | Methods and compositions for modulating beta-catenin phosphorylation | |
| ATE343002T1 (de) | Verfahren zur isolation des 20s proteasoms, und verfahren zur identifikation von inhibitoren des 20s und 26s proteasoms | |
| ATE461290T1 (de) | Verfahren zur identifizierung von aktivestellen- proteasinaktivatoren | |
| DE69932342D1 (de) | Verfahren und zusammensetzungen zur hemmung von neoplastischem zellwachstums | |
| AU2003241604A1 (en) | System and method for screening for protease inhibitors and proteases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 906333 Country of ref document: ES |